Non-ownership Filings
| Letter to Shareholders – 2025 a year of progress | Dec. 18, 2025 |
| POLB 001 European Patent granted | Nov. 20, 2025 |
| Interim Results for the six months to 30 June 2025 | Sep. 29, 2025 |
| Results of GM and AGM Meetings | Jun. 23, 2025 |
| FDA Orphan Drug Designation granted for POLB 001 | May. 27, 2025 |
| Annual Report, AGM Notice & Circular | May. 27, 2025 |
| Result of upsized oversubscribed BookBuild Offer | May. 23, 2025 |
Ownership Update Filings
| Notification of Major Holdings | Jul. 01, 2025 |
| Notification of Major Holdings | Jun. 26, 2025 |
| Director/PDMR Shareholding | Jun. 25, 2025 |
| Holding(s) in Company | Feb. 18, 2025 |
| Holding(s) in Company | Jan. 09, 2025 |
| Holding(s) in Company | Aug. 12, 2024 |
| Notification of Major Holdings | Jul. 10, 2024 |